For research use only. Not for therapeutic Use.
Kigamicin C was discovered by an anti-austerity strategy, targeting cancer cells/’ tolerance to starvation. It selectively kills PANC-1 cells (a pancreatic cell line) at concentrations 100 times lower under nutrient starved conditions than in normal conditions. It is active in vivo against a human pancreatic cancer xenograft model. Kigamicin C also inhibits the growth of Gram positive bacteria including MRSA, but is not active against Gram negative bacteria.</br>The mechanism of action is proposed to be via blockade of aPKB/Akt activation, caused by the withdrawal of nutrients.
Catalog Number | R003515 |
CAS Number | 680571-51-1 |
Synonyms | (1S,3R,4S,8aR,11aR)-3-[[(2S,5S,6R)-5-[(2,6-dideoxy-3-O-methyl-b-D-arabinohexopyranosyl)oxy]tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-1,2,3,4,8a,9,11,11a,13,14-decahydro-1,4,17,18-tetrahydroxy-11a-methyl-oxazolo[3,2-b]xantheno[4/’,3/’,2/’:4,5][1,3]benzod |
Molecular Formula | C41H47NO16 |
Purity | ≥95% |
Target | Bacterial |
Storage | -20°C |
InChI | InChI=1S/C41H47NO16/c1-15-20(56-25-12-22(50-4)32(44)16(2)55-25)5-6-24(54-15)57-23-11-19(43)28-35(47)31-36(48)30-26-17(9-18-13-41(3)42(7-8-53-41)40(49)27(18)34(26)46)10-21-29(30)38(52-14-51-21)39(31)58-37(28)33(23)45/h9,15-16,19-25,32-33,43-46,48H,5-8,10-14H2,1-4H3/t15-,16-,19+,20+,21-,22-,23-,24+,25+,32-,33+,41-/m1/s1 |
InChIKey | JXSADZFORZMJRI-KUPVXKSBSA-N |
SMILES | CC1C(CCC(O1)OC2CC(C3=C(C2O)OC4=C(C3=O)C(=C5C6=C4OCOC6CC7=CC8=C(C(=C75)O)C(=O)N9CCOC9(C8)C)O)O)OC1CC(C(C(O1)C)O)OC |
Reference | Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells/’ tolerance to nutrient starvation. Lu J. et al. Cancer Sci. 2004, 95, 547.<br/><br/>Kigamicins, novel antitumor antibiotics. II. Structure determination. Kunimoto S. et al. J. Antibiot. 2003, 56, 1012.<br/><br/>Kigamicins, novel antitumor antibiotics. I. Taxonomy, isolation, physico-chemical properties and biological activities. Kunimoto S. et al. J. Antibiot. 2003, 56, 1004.</span></p> |